Index> News >Company  
 

Morimatsu has received an order from a Chinese corporation to execute a Conceptual & Basic Design study for a new Biopharmaceutical MAB productionfacility project in China. The extended study will involve engineering departments both in Stockholm and Shanghai offices.

The study will be completed during Q1 2017. The scope of delivery includes the following disciplines: Process, Facility, Quality and Regulatory.

This project is another most successful prove of that Morimatsu modular facility solutions/ process equipment's and engineering services is highly attractive on the worldwide market. The company won this order in high competition by other International and well recognized engineering and equipment providers.

 
 
Copyright © 2010 Life Science and Consumer Products Division 备案号:10038870